++
Chapter 22: Growth, Thyroid, and Gonadal Pharmacology
++
++
++
Growth hormone does not play a key role in which of the following physiologic actions?
++
++
++
a. Regulation of protein, fat, and carbohydrate metabolism
++
++
b. Regulation of normal adult height
++
++
c. Regulation of lean body mass
++
++
d. Regulation of secondary sexual characteristics
++
++
++
Which of the following would stimulate gonadotropin (FSH and LH) secretion?
++
++
++
a. Continuous nonpulsatile administration of gonadotropin-releasing hormone
++
++
b. Pulsatile administration of gonadotropin-releasing hormone
++
++
c. Gonadotropin-releasing hormone antagonists
++
++
++
++
++
Which of the following drugs is not associated with an increased risk of thromboembolic events?
++
++
++
++
++
++
++
c. Hormonal contraceptives
++
++
++
++
++
Which of the following is true regarding treatment of hypothyroidism?
++
++
++
a. Synthetic T4 (levothyroxine) is usually the first choice.
++
++
b. Synthetic T3 (liothyronine) is usually the first choice.
++
++
c. Thyroid-stimulating hormone (TSH) is usually the first choice.
++
++
d. Thyrotropin-releasing hormone (TRH) is usually the first choice.
++
++
++
Which of the following would be anticipated in an individual taking growth hormone in supraphysiological doses as a performance-enhancing drug?
++
++
++
++
++
++
++
++
++
++
++
++
Potential treatments for an individual with hyperthyroidism does not include which of the following?
++
++
++
a. Radioactive iodine therapy using 131I
++
++
++
++
c. Radioactive synthetic T4
++
++
d. Surgical removal of the thyroid gland
++
++
++
Which of the following conditions is likely to be treated with recombinant forms of human growth hormone?
++
++
++
++
++
++
++
++
++
d. Acquired immune deficiency ...